Development and multi-center clinical trials of an up-converting phosphor technology-based point-of-care (UPT-POCT) assay for rapid COVID-19 diagnosis and prediction of protective effects

BACKGROUND: Quantitative point-of-care testing assay for detecting antibodies is critical to COVID-19 control. In this study, we established an up-conversion phosphor technology-based point-of-care testing (UPT-POCT), a lateral flow assay, for rapid COVID-19 diagnosis, as well as prediction of seral...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Pingping, Li, Baisheng, Wang, Yao, Min, Wei, Wang, Xiaohui, Zhou, Yugui, Li, Zhencui, Zhao, Yong, Zhang, Huan, Jiang, Min, Zheng, Huanying, Yang, Chao, Zhang, Wei, Zuo, Le, Gao, Qi, Yang, Zhengrong, Li, Yanzhao, Feng, Tiejian, Lin, Changqing, Hu, Qinghua, Song, Tie, Yang, Ruifu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811342/
https://www.ncbi.nlm.nih.gov/pubmed/35114938
http://dx.doi.org/10.1186/s12866-022-02450-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811342/
https://www.ncbi.nlm.nih.gov/pubmed/35114938
http://dx.doi.org/10.1186/s12866-022-02450-z

Ejemplares similares